Published in J Exp Clin Cancer Res on April 05, 2016
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (1999) 83.27
BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell (2003) 13.47
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell (2002) 11.83
A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol (2002) 7.12
Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature (1999) 6.50
Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med (2011) 5.24
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nat Genet (2011) 4.93
TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. Cancer Cell (2010) 3.69
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol (2000) 3.50
Acute lymphoblastic leukaemia. Lancet (2013) 3.44
Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA (2003) 3.07
A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia. Blood (2012) 2.65
Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell (2003) 2.53
Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol (2000) 2.40
Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood (2002) 2.17
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia (2012) 1.93
Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers. Clin Cancer Res (2008) 1.90
Id proteins synchronize stemness and anchorage to the niche of neural stem cells. Nat Cell Biol (2012) 1.89
ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21. Cancer Cell (2012) 1.70
The ID proteins: master regulators of cancer stem cells and tumour aggressiveness. Nat Rev Cancer (2014) 1.70
Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL). Hematol Oncol Clin North Am (2000) 1.69
Id sustains Hes1 expression to inhibit precocious neurogenesis by releasing negative autoregulation of Hes1. Dev Cell (2007) 1.56
Right on target: eradicating leukemic stem cells. Trends Mol Med (2007) 1.49
Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood (2004) 1.49
Associations between genome-wide Native American ancestry, known risk alleles and B-cell ALL risk in Hispanic children. Leukemia (2013) 1.33
Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential. Biochem Pharmacol (2001) 1.24
Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples. Cancer Sci (2008) 1.23
Late effects of acute lymphoblastic leukemia therapy in patients diagnosed at 0-20 years of age. Hematology Am Soc Hematol Educ Program (2011) 1.16
Id1 maintains embryonic stem cell self-renewal by up-regulation of Nanog and repression of Brachyury expression. Stem Cells Dev (2011) 1.11
Bcr-Abl variants: biological and clinical aspects. Leuk Res (2002) 1.11
Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F. Cancer Res (2010) 1.09
Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways. Clin Cancer Res (2009) 1.08
Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations. Oncotarget (2013) 1.07
Incidence rates of the major leukemia subtypes among US Hispanics, Blacks, and non-Hispanic Whites. Leuk Lymphoma (2006) 1.03
Prognostic factors in adult acute lymphoblastic leukaemia. Br J Haematol (2010) 1.01
NF-kappaB as a therapeutic target in chronic lymphocytic leukemia. Expert Opin Ther Targets (2010) 0.99
Id1 transcription inhibitor-matrix metalloproteinase 9 axis enhances invasiveness of the breakpoint cluster region/abelson tyrosine kinase-transformed leukemia cells. Cancer Res (2006) 0.98
Transcriptional profiling of gastric epithelial cells infected with wild type or arginase-deficient Helicobacter pylori. BMC Microbiol (2012) 0.95
A 41-gene signature derived from breast cancer stem cells as a predictor of survival. J Exp Clin Cancer Res (2014) 0.93
Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B-cell acute lymphoblastic leukemia. Am J Hematol (2014) 0.92
Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis. J Exp Clin Cancer Res (2015) 0.91
Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia. Haematologica (2010) 0.91
Cytogenetic and molecular predictors of outcome in acute lymphocytic leukemia: recent developments. Curr Hematol Malig Rep (2012) 0.89
Id-1 promotes TGF-beta1-induced cell motility through HSP27 activation and disassembly of adherens junction in prostate epithelial cells. Exp Cell Res (2007) 0.89
Leukemia mortality trends among children, adolescents, and young adults in Latin America. Rev Panam Salud Publica (2011) 0.89
E47 and Id1 interplay in epithelial-mesenchymal transition. PLoS One (2013) 0.88
Characteristic gene expression profiles in the progression from liver cirrhosis to carcinoma induced by diethylnitrosamine in a rat model. J Exp Clin Cancer Res (2009) 0.87
Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma. Blood (2015) 0.86
Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance. Radiother Oncol (2011) 0.85
R4 Regulator of G Protein Signaling (RGS) Proteins in Inflammation and Immunity. AAPS J (2015) 0.84
Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma. PLoS One (2014) 0.84
A quantitative genomic expression analysis platform for multiplexed in vitro prediction of drug action. Pharmacogenomics J (2005) 0.83
Glycogen synthase kinase-3β inhibition induces nuclear factor-κB-mediated apoptosis in pediatric acute lymphocyte leukemia cells. J Exp Clin Cancer Res (2010) 0.83
Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol. J Clin Oncol (1989) 0.81
Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: results from an Australian population. Leuk Lymphoma (2010) 0.81
Classification of acute leukemias. Semin Diagn Pathol (2003) 0.81
Factors that contribute to long-term survival in patients with leukemia not in remission at allogeneic hematopoietic cell transplantation. J Exp Clin Cancer Res (2011) 0.78
Role of high expression of IL-9 in prognosis of CLL. Int J Clin Exp Pathol (2014) 0.78
Outcome of treatment with Hyper-CVAD regimen in Chinese patients with acute lymphocytic leukemia. Leuk Res (2007) 0.77
[Comparison of the Hyper-CVAD with an institutional regimen for the treatment of acute lymphoblastic leukemia in adults in a hospital of Mexico]. Rev Peru Med Exp Salud Publica (2014) 0.76
[Acute lymphoblastic leukemia: experience in adult patients treated with hyperCVAD and 0195 Protocol, at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Cohort 2003-2007]. Rev Invest Clin (2009) 0.76